KCT0009157尚未招募Unknown
Clinical impact of SGLT2 inhibitor after DC cardioversion in persistent atrial fibrillation patients with heart failure with preserved ejection fraction: A Randomized Controlled Trial
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19(Year) 至 o Limit（—）
- 性别
- All
入选标准
- •? Patients aged 19 or more
- •? Patients with persistent atrial fibrillation
- •? H2FPEF diagnostic criteria of 6 or more or HFA-PEFF diagnostic criteria of 5 or more
- •? Patients who have converted to sinus rhythm after DC cardioversion
排除标准
- •? Patients who used SGLT2 inhibitors in the past
- •? Patients with less than 45 creatinine clearance
- •? Patients with intracardiac thrombus confirmed by transesophageal echocardiography
- •? Patients who refused to participate in the study
研究者
相似试验
尚未招募
不适用
PRE, post-treatment of SGLT-2 Inhibitor on myocardial infarct size and remodeling index in patients with AMI and high risk of heart failure undergoing PCI (PRESTIGE-AMI)Diseases of the circulatory systemKCT0006219Samsung Medical Center200
尚未招募
不适用
The impact of the SGLT2 inhibitor on cardiovascular risk factors in patients with type 2 diabetes, an explanatory randomized trialType 2 diabetesJPRN-UMIN000021669Tokyo Medical University60
已完成
不适用
Effects of treatment with SGLT2 inhibitor on the initiation of continuous positive airway pressure therapy in type 2 diabetic patients with obstructive sleep apnea syndromeType 2 diabetesJPRN-UMIN000045226Akishima Clinic16
招募中
不适用
Observation study to asses the effect of SGLT2 inhibitors on cardiac uptake of FDGEndocrine, nutritional and metabolic diseaseKCT0004869lsan Univeristy Hospital30
已完成
不适用
The effect of SGLT2 inhibitor on diabetic kidney disease-Examination by MRIDiabetic Kidney DiseaseJPRN-UMIN000036523ational Hospital Organization, Kagosima Medical Center20